Grieving families are mourning at least 279 killed when a London-bound passenger jet crashed in India, with the victims in ...

The FDA has approved Widaplik, a polypill combining telmisartan, amlodipine, and indapamide, for the treatment of ...

The FDA has approved Widaplik (telmisartan, amlodipine and indapamide) for the treatment of hypertension, including as initial treatment, to lower blood pressure.

The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of ...

RayzeBio, the radiopharmaceutical unit of Bristol Myers Squibb, licensed an experimental drug and diagnostic agent for prostate cancer from Philochem AG for a $350 million upfront payment. Philochem ...

The FDA has approved a polypill as an initial treatment for hypertension in adults for the first time. Here’s what to know: 1. Widaplik — manufactured by George Medicines — is a polypill that contains ...

The FDA has approved Widaplik, a triple-drug combination, for the treatment of hypertension in adults.

This story first appeared in How We Care, a weekly newsletter by Spotlight PA featuring original reporting and perspectives on how we care for one another at all stages of life. Sign up for free here.

By Lori Solomon HealthDay ReporterWEDNESDAY, June 11, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...

Widaplik marks the first and only FDA-approved triple combination medication that can be used as an initial therapy for patients with hypertension who require multiple drugs to reach their blood ...

The combination will be available in several doses and is also approved as a first-line option for patients with hypertension ...

George Medicines announced the FDA approval of its triple therapy polypill for initial treatment of adults with ...